This Mutation Likely Saved a Colon Cancer Patient's Life
His tumor had a specific genetic makeup known as mismatch repair-deficient, present in 5% to 10% of all rectal cancer patients, meaning he might qualify for a cutting-edge immunotherapy. (Source: WebMD Health)
Source: WebMD Health - March 18, 2024 Category: Consumer Health News Source Type: news

Racial Disparities Seen for Locally Advanced Rectal Cancer Outcomes
THURSDAY, March 7, 2024 -- Treatment outcomes for locally advanced rectal cancer (LARC) are less favorable for Hispanic and non-Hispanic Black patients versus non-Hispanic White patients, according to a study published online Feb. 29 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 7, 2024 Category: Pharmaceuticals Source Type: news

Transcatheter Arterial Chemoembolization for Rectal Tumors? Transcatheter Arterial Chemoembolization for Rectal Tumors?
Chinese investigators have applied a technique long used for liver metastases to rectal cancer, with promising results.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 19, 2024 Category: Gastroenterology Tags: Hematology-Oncology Source Type: news

Regrowth Predicts Metastasis in Rectal Cancer Watch and Wait Regrowth Predicts Metastasis in Rectal Cancer Watch and Wait
A large retrospective study addressed the risk of opting for " watch and wait " in rectal cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 7, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

New Treatment Approach Good News for People Battling Rectal Cancers
MONDAY, Feb. 5, 2024 -- Rectal cancer often involves surgeries that can lead to a debilitating loss of bowel function for patients. However, new research suggests that a less aggressive approach to treating the disease has helped an increasing... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 5, 2024 Category: General Medicine Source Type: news

Standard Therapy Beats Out Primary Surgery in Rectal Cancer Standard Therapy Beats Out Primary Surgery in Rectal Cancer
In locally advanced rectal cancer, primary surgery followed by selective adjuvant chemoradiation was inferior to standard neoadjuvant preoperative chemoradiation followed by surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 17, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news

Long-Term Organ Preservation in Rectal Cancer Is Possible Long-Term Organ Preservation in Rectal Cancer Is Possible
Long-term data from the OPRA trial show organ preservation at 5 years in about half of patients with stage II/III rectal adenocarcinoma who received total neoadjuvant therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Surgery Is Falling Out of Favor in Rectal Cancer Surgery Is Falling Out of Favor in Rectal Cancer
With organ preservation on the rise, investigators say practice guidelines need to catch up.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 20, 2023 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Global Surge In Colo-Rectal Cancer Linked To Junk Food
Scientists have found a link between a recent global surge in colorectal cancer and processed or “junk” food. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 31, 2023 Category: Pharmaceuticals Authors: Daphne Ewing-Chow, Senior Contributor Tags: Food & Drink /food-drink Business /business Innovation /innovation Healthcare /healthcare standard Source Type: news

Predicting Recurrence in Rectal Cancer Watchful Waiting Predicting Recurrence in Rectal Cancer Watchful Waiting
Investigators reported that the Immunoscore biopsy, which quantifies immune cell tumor infiltration, is a strong predictor of recurrence during watchful waiting for rectal cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 19, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

NCI Task Force Issues Rectal Cancer Trial Design Recs NCI Task Force Issues Rectal Cancer Trial Design Recs
The consensus recommendations address key areas in rectal cancer trial design, including the need to incorporate endpoints important to patients and establish the optimal use of neoadjuvant therapy.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - August 16, 2023 Category: Gastroenterology Tags: Hematology-Oncology Source Type: news

Does Timing of Surgery Affect Rectal Cancer Outcomes? Does Timing of Surgery Affect Rectal Cancer Outcomes?
Waiting more than 12 weeks for surgery following neoadjuvant therapy was associated with improved tumor regression grade and reduced risk of systemic recurrence but not overall survival.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 14, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Episode 3: Treating Rectal Cancer: PROSPECT, PRODIGE, or OPRA? Episode 3: Treating Rectal Cancer: PROSPECT, PRODIGE, or OPRA?
Join Drs Benjamin Schlechter and Harvey Mamon as they discuss treatment options for patients with stage II and III rectal cancer based on new data from the most recent clinical trial results.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 6, 2023 Category: Consumer Health News Tags: Radiology InDiscussion Source Type: news

Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer? Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer?
Neoadjuvant chemoradiotherapy can be omitted in low-risk rectal cancer patients without compromising outcomes, but intensified in high-risk patients, new findings suggest.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 27, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

MRI Identifies Rectal Cancer Patients Who Can Skip CRT MRI Identifies Rectal Cancer Patients Who Can Skip CRT
Patients with stage I-III rectal cancer typically undergo chemoradiation before surgery, but MRI can identify those who could skip this step and go straight to upfront surgery.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 26, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news